Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 129, 27-33
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyThe Lancet, 2013
- Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: A meta-analysis of 8 randomized trialsAtherosclerosis, 2012
- Role of the laboratory in monitoring patients receiving dual antiplatelet therapyInternational Journal of Laboratory Hematology, 2012
- ADORA2A Gene Variation, Caffeine, and Emotional Processing: A Multi-level Interaction on Startle ReflexNeuropsychopharmacology, 2011
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trialThe Lancet, 2010
- The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese populationBehavioral and Brain Functions, 2010
- A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol effluxJournal of Leukocyte Biology, 2010
- Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent ThrombosisThe American Journal of Cardiology, 2009
- Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced AnxietyNeuropsychopharmacology, 2008
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007